Archives
-
CBD in Orofacial Pain: Mechanisms and Implications
2026-09-02
A 2026 Brain Research Bulletin study shows that cannabidiol (CBD) can reduce inflammatory orofacial pain while also improving pain-associated affective and cognitive abnormalities in mice. Its main contribution is a multisite mechanistic model linking peripheral CB2 signaling, central CB1 pathways, endocannabinoid metabolism, inflammatory and oxidative processes, and serotonin dynamics.
-
Dual HER2–VEGFR2 Targeting in TNBC Metastasis
2026-09-02
The reference study examines lapatinib plus Telatinib (BAY 57-9352) as a dual tyrosine kinase inhibition strategy in HER2-negative MDA-MB-231 triple-negative breast cancer cells. Combined treatment reduced proliferation, invadopodia formation, and endothelial tube formation, supporting further investigation while leaving pharmacological synergy, target engagement, and in vivo efficacy unresolved.
-
Ferrocenyl Novobiocin Derivatives: Study Insights
2026-09-01
The reference study introduced ferrocenyl novobiocin derivatives as a bioorganometallic strategy for improving activity against Plasmodium falciparum and breast cancer cells. Its matched comparison with organic analogues suggests that ferrocene incorporation can enhance biological performance, while also highlighting the need for mechanism-focused and selectivity studies.
-
SAG, Sex-Dependent Immunity, and CNS Remyelination
2026-09-01
The 2024 Cells study shows that the Smoothened receptor agonist SAG supports remyelination but changes peripheral immune responses differently in male and female demyelination models. Its central implication is that Hedgehog agonism and testosterone cannot be assumed to cooperate similarly across sexes, making immune profiling an essential component of regenerative therapy studies.
-
GTP Solution for p21 mRNA–LNP Workflows
2026-08-31
A practical guide to using high-purity GTP in IVT mRNA, RNA amplification, and localized lipid nanoparticle workflows. Learn how nucleotide handling can improve reproducibility while keeping clear boundaries between reagent performance and therapeutic conclusions.
-
DeferoxamineB in Ferroptosis Assay Design
2026-08-31
DeferoxamineB is more than an iron chelator: it is a mechanistic control for separating iron-dependent ferroptosis from copper-driven cell death. This article explains how to position Deferoxamine in metabolic oncology assays without confusing pathway rescue, antioxidant effects, apoptosis, or autophagy.
-
Ibotenic Acid Workflows for Neurodegeneration Models
2026-08-30
Ibotenic acid provides a mechanistically defined way to perturb glutamatergic circuits while tracking behavioral, biochemical, immediate-early gene, and neuronal injury endpoints. This workflow guide translates dose- and time-dependent toxicity findings into practical assay design, stock-preparation, sampling, and troubleshooting decisions.
-
Cy5 NHS ester(Et): Practical Labeling Guide
2026-08-29
Cy5 NHS ester(Et) is a water-soluble reagent for attaching a Cy5 fluorophore to primary amines in proteins, peptides, and other biomolecules. It is suitable for immediate-use protein fluorescent labeling, immunofluorescence staining, flow cytometry, and fluorescence microscopy, but it should not be used in ethanol-based protocols or for long-term storage of dissolved solutions.
-
Deferoxamine in Ferroptosis Assay Design
2026-08-28
Deferoxamine and DeferoxamineB are more than iron-chelation tools: they can function as causal probes for separating ferroptosis, cuproptosis, apoptosis, and autophagy in cancer models. This article presents an assay-first framework for interpreting metal-dependent cell death without overstating what a chelator rescue experiment proves.
-
Cerulenin Blocks Leucomycin Biosynthesis
2026-08-28
Takeshima, Kitao, and Omura showed that cerulenin selectively suppresses leucomycin production in Streptomyces kitasatoensis by disrupting acetate incorporation into the macrolide aglycone. Their growing-cell, resting-cell, radiotracer, and recovery experiments provided early functional evidence that macrolide assembly uses a polyketide condensation pathway related to fatty acid biosynthesis.
-
Lamotrigine Assay Workflows for CNS and Cardiac Research
2026-08-27
Build reproducible Lamotrigine experiments around controlled solubilization, voltage-clamp measurements, and orthogonal serotonin-pathway readouts. The workflow also shows how metabolism-focused HPLC-MS logic can strengthen CNS and cardiac assay interpretation without overstating evidence from unrelated compounds.
-
β-Elemene: Mechanisms and Research Workflow
2026-08-27
β-Elemene, also called Levo-β-elemene, is a plant-derived sesquiterpene used in apoptosis, metabolic, inflammation, and neuroprotection research. Evidence includes AMPK-associated inhibition of adipogenesis in 3T3-L1 cells, while PI3K/AKT/mTOR and spinal cord injury findings remain context-dependent and predominantly preclinical.
-
SCP4, H3T3 Dephosphorylation, and Chromosome Stability
2026-08-26
The reference study identifies the nuclear phosphatase SCP4 as a mitotic histone H3T3 phosphatase, resolving an important gap in how Haspin-dependent phosphorylation is balanced during cell division. Cellular and mouse-zygote evidence connects abnormal SCP4 regulation with defective chromosome segregation, lagging chromosomes, and aneuploidy.
-
0.4% Trypan Blue Solution: Practical QC Guide
2026-08-26
0.4% Trypan Blue Solution provides a direct way to estimate cell viability and distinguish unstained viable cells from blue-stained dead or membrane-damaged cells in cultured samples. It is intended for research workflows such as cell counting and cytotoxicity assays, but not for diagnostic, medical, or mechanism-specific apoptosis and necrosis testing.
-
Novobiocin: An Assay-First Translational Framework
2026-08-25
Novobiocin is an aminocoumarin antibiotic with coordinated antibacterial, antiparasitic, and antiviral research value. This assay-first guide connects molecular mechanism, selectivity evidence, concentration selection, formulation, and translational limitations for better experimental decisions.